India Positioning Itself to Mitigate Oil Price Volatility Amid Middle East Tensions

Market Outlook and Investment Strategies

Carnelian Capital's Founder, Swati Khemani, Highlights Key Trends and Opportunities

Market Volatility and Geopolitics

Crude oil prices may remain volatile as long as tensions in the Middle East persist. India's ability to manage its energy supplies pragmatically, as seen during the Russia-Ukraine conflict, suggests the country is relatively better positioned to absorb such shocks.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Defence Spending and Global Trends

Major economies are increasing their defence spending, with the US at around 3.4% of GDP, Russia at around 7%, and China at around 2%. India's defence budget for FY26 is Rs 6.81 lakh crore, about 1.9% of GDP, and is expected to increase to 2.5% of GDP.

Economic Growth and Market Returns

India's economy is structurally strong, with a stable fiscal health, corporate balance sheets, and household leverage. Despite short-term risks, economic growth is expected to remain strong, with growth expected to pick up across sectors. Market returns are expected to be better than last calendar year, with earnings expected to improve in FY27.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Investment Themes and Sectors

Carnelian Capital remains highly bullish on Banks, CDMO, Consumption, and Manufacturing. Select pharma exporters, capital goods companies with strong order books, and well-capitalised private financials may see rerating as earnings visibility strengthens.

Women's Participation in Equity Markets

Women's participation in the equity markets has increased significantly in India over the past few years, with women accounting for roughly 20-25% of new demat account openings and holding 33% of mutual fund Assets Under Management (AUM).

Investment Strategies

Investors should consider long-term wealth creation opportunities in sectors such as Banks, CDMO, Consumption, and Manufacturing, as well as select pharma exporters, capital goods companies with strong order books, and well-capitalised private financials.